Peptide Bioregulators Explained: Epithalon, Cortagen, Cartalax

For laboratory research use only. Not for human or veterinary use.

Bioregulators are a distinct and often misunderstood category of research peptide. They come from a specific scientific tradition, they're structurally unusual, and they're studied differently from the better-known signalling peptides.

Where they come from#

Peptide bioregulators emerged from Soviet and later Russian research beginning in the 1970s, associated primarily with the St Petersburg Institute of Bioregulation and Gerontology. The research programme investigated short peptides isolated from animal tissues, and later synthesised versions of the same sequences.

Much of the foundational literature was published in Russian, which is part of why these compounds are less familiar in English-language research than peptides of Western origin. The body of work is substantial but unevenly translated.

What makes them structurally distinct#

Most research peptides are moderately sized — often 15 to 40 amino acids. Bioregulators are strikingly short, typically two to four residues.

Epithalon, for instance, is a tetrapeptide: alanine-glutamate-aspartate-glycine. Four amino acids. That's small even by peptide standards.

The theoretical framework proposed for them is tissue-specific gene regulation — the hypothesis being that these very short sequences interact with DNA or chromatin-associated proteins to influence transcription in particular tissue types. Each bioregulator is associated in the literature with a specific tissue of origin.

It's worth being clear-eyed: this remains an area where the mechanistic evidence base is less developed than for well-characterised receptor-binding peptides, and much of the supporting work sits outside mainstream Western literature. That's a legitimate reason for research interest and equally a reason for methodological caution.

The main compounds#

Epithalon — a tetrapeptide studied in relation to telomerase activity and circadian regulation. The most widely known of the group, and the one with the largest English-language literature.

Cortagen — associated in the literature with nerve and connective tissue, studied in peripheral nerve research models.

Crystagen — studied in immune-system research contexts.

Cartalax — associated with cartilage and connective tissue, appearing in joint and vascular research literature.

Thymosin alpha-1 — sometimes grouped here, though it sits somewhat apart: it's longer at 28 residues, has a substantially larger Western literature, and is studied extensively in immunological research.

Practical handling#

Short peptides are not automatically more robust. Standard practice applies:

• Lyophilised material stored at 2–8°C, protected from light and moisture
• Reconstituted with bacteriostatic or sterile water — see the solvent guide
• Solvent run down the vial wall, never onto the powder; swirl, never shake
• Reconstituted material refrigerated and used within its stability window

One genuine advantage of very short sequences: fewer coupling steps during synthesis means fewer opportunities for truncation errors, which is one reason well-made bioregulators often show figures. That's a reason to expect a good number, not a reason to skip verifying it.

Verification matters more here, not less#

Because the literature is fragmented and the market smaller, documentation discipline is particularly important with this group.

A four-residue peptide has a low molecular weight, which makes mass-spectrometry identity confirmation straightforward and unambiguous. There's no good reason for a supplier to omit it. Insist on seeing both purity and identity data — see how to read a COA and what a purity figure actually means.

Sources#

Status elsewhere: The tissue-extract preparations these peptides were derived from, such as Epithalamin and Cortexin, have been used clinically in Russia.

Each entry links to its PubMed record, where the title and abstract can be read. The descriptions are ours: they say what each paper examined, not what it is claimed to show. Records checked on PubMed on 28 October 2026.

1. Khavinson VK, Popovich IG, Linkova NS, et al. (2021). Molecules 26(22):7053. Systematic review by the St Petersburg group setting out their gene-regulation hypothesis for short peptides. PubMed 34834147
2. Khavinson VKh, Kuznik BI, Ryzhak GA (2013). Adv Gerontol 26(1):20–37. (in Russian) Review of the St Petersburg group’s clinical studies of their peptide preparations, including Epithalamin and Cortexin. PubMed 24003726
3. Khavinson VKh, Bondarev IE, Butyugov AA, et al. (2004). Bull Exp Biol Med 137(5):503–6. Epithalon and telomere length in cultured human fetal fibroblasts, from the originating group. PubMed 15455129
4. Korkushko OV, Lapin BA, Goncharova ND, et al. (2007). Adv Gerontol 20(1):74–85. (in Russian) Study of pineal peptide preparations, including synthetic Epitalon, and night-time melatonin levels in old monkeys and elderly people. PubMed 17969590
5. Al-Dulaimi S, Thomas R, Matta S, et al. (2025). Biogerontology 26(5):178. Independent cell study from Brunel University London of epitalon and telomere length in normal and breast-cancer cell lines. In the cancer lines the lengthening ran through a telomerase-independent route (ALT). PubMed 40908429
6. Jain A, Gallacher DM, Issa MA, et al. (2026). Int J Mol Sci 27(19):8922. Independent narrative review. Concludes that epitalon is biologically active but clinically unproven, with the human evidence limited to small studies. PubMed 42884164
7. Turchaninova LN, Kolosova LI, Malinin VV, et al. (2000). Bull Exp Biol Med 130(12):1172–4. Rat study of Cortagen measuring nerve-fibre growth rate and conduction velocity after the sciatic nerve was cut and sutured. PubMed 11276314
8. Anisimov SV, Khavinson VKh, Anisimov VN (2004). Neuro Endocrinol Lett 25(1-2):87–93. Mouse microarray study of gene expression in the heart after Cortagen. States the sequence as Ala-Glu-Asp-Pro. PubMed 15159690

In our catalogue#

• Epithalon — telomerase and circadian research
• Cortagen — nerve and connective tissue research
• Crystagen — immune regulation research
• Cartalax — cartilage and vascular research
• Thymosin alpha-1 — immune research
• FOXO4-DRI — cellular senescence research

Ask about the documentation for the batch we would ship before you order.

Pioneer Research Peptides — UK supplier of research peptides.

For laboratory research use only — not for human consumption. 18+.